Our Investment Approach
We use disciplined Value for Growth investment approaches for private equity investments and for late stage pre-IPO venture capital companies, preferably in the USA but with global market opportunities, that are at the stage of commercializing and selling their products.
We are not interested in and do not invest in early stage venture capital situations. We are not Angel investors.
We do not invest in commodity oriented situations. We look for and have niche market investments of interest.
Companies that interest us must offer:
While we need control or contingent control of investee companies, we simultaneously require excellent management to work with that has vision and strategic expertise and is fully capable of strong operational execution.
We avoid industries and companies subject to large commodity price exposure and prefer companies that are focused on niche markets, have significant market share and enjoy pricing power for their products.
Our existing core investments have strong technological foundations, have disruptive market capabilities, are showing strong recent growth, have a high and accelerating level of credibility in their market, are capable of sustained explosive growth, typically have an outstanding leader recognized as a world-class expert in the area, have well advanced products or services with good market share and market penetration rates in large North American or global commercial markets.
We have high controlling percentages of ownership employing substantial equity or convertible investments in our core investments in each of medical devices, certain software, certain supply chain management and certain areas of healthcare.
We use disciplined Value for Growth investment approaches for private equity investments and for late stage pre-IPO venture capital companies, preferably in the USA but with global market opportunities, that are at the stage of commercializing and selling their products.
We are not interested in and do not invest in early stage venture capital situations. We are not Angel investors.
We do not invest in commodity oriented situations. We look for and have niche market investments of interest.
Companies that interest us must offer:
- excellent products or services;
- strong strategic management;
- large addressable markets;
- high margins;
- competitive advantage;
- sustainable growth and scalability;
- control or contingent control;
- Kinetic Capital Partners must be able to employ substantial capital; and
- investment cost must be attractive relative to value, growth and risk.
While we need control or contingent control of investee companies, we simultaneously require excellent management to work with that has vision and strategic expertise and is fully capable of strong operational execution.
We avoid industries and companies subject to large commodity price exposure and prefer companies that are focused on niche markets, have significant market share and enjoy pricing power for their products.
Our existing core investments have strong technological foundations, have disruptive market capabilities, are showing strong recent growth, have a high and accelerating level of credibility in their market, are capable of sustained explosive growth, typically have an outstanding leader recognized as a world-class expert in the area, have well advanced products or services with good market share and market penetration rates in large North American or global commercial markets.
We have high controlling percentages of ownership employing substantial equity or convertible investments in our core investments in each of medical devices, certain software, certain supply chain management and certain areas of healthcare.